Evotec (OTCMKTS:EVTCY) Stock Price Passes Below 50-Day Moving Average - Time to Sell?

Key Points

• Evotec SE (OTCMKTS:EVTCY) stock has fallen below its fifty-day moving average of $4.07, trading as low as $3.76, and currently sits at $3.82.
• The company has a market cap of $1.26 billion, a PE ratio of 9.32, and a debt-to-equity ratio of 0.53.
• Evotec specializes in the discovery and development of new drugs for pharmaceutical and biotechnology companies, operating under segments EVT Execute and EVT Innovate.

Evotec SE (OTCMKTS:EVTCY - Get Free Report)'s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $4.07 and traded as low as $3.76. Evotec shares last traded at $3.82, with a volume of 55,918 shares traded.

Evotec Stock Performance

The business has a 50 day moving average of $4.04 and a 200 day moving average of $3.97. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $1.18 billion, a P/E ratio of 8.71 and a beta of 0.98.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.